Patents by Inventor Stanley Freeman

Stanley Freeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200109092
    Abstract: Reaction products and methods for making and using such reaction products are provided. For example, a reaction product comprising an adduct formed from two or more of a first nucleophile (e.g., including, but not limited to, a urease inhibitor), a second nucleophile, and an electrophile is described, which can be provided in various forms. Such a reaction product can be in the form of a solid or solution. Such a reaction product can also be combined with one or more additional components, including but not limited to, free urease inhibitor and/or a nitrogen-based fertilizer composition.
    Type: Application
    Filed: December 5, 2019
    Publication date: April 9, 2020
    Inventors: Douglas Barr, Ethel Garnier, Stanley Freeman
  • Patent number: 10501384
    Abstract: Reaction products and methods for making and using such reaction products are provided. For example, a reaction product comprising an adduct formed from two or more of a first nucleophile (e.g., including, but not limited to, a urease inhibitor), a second nucleophile, and an electrophile is described, which can be provided in various forms. Such a reaction product can be in the form of a solid or solution. Such a reaction product can also be combined with one or more additional components, including but not limited to, free urease inhibitor and/or a nitrogen-based fertilizer composition.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: December 10, 2019
    Assignee: Koch Agronomic Services, LLC
    Inventors: Douglas Barr, Ethel Garnier, Stanley Freeman
  • Publication number: 20180208520
    Abstract: Reaction products and methods for making and using such reaction products are provided. For example, a reaction product comprising an adduct formed from two or more of a first nucleophile (e.g., including, but not limited to, a urease inhibitor), a second nucleophile, and an electrophile is described, which can be provided in various forms. Such a reaction product can be in the form of a solid or solution. Such a reaction product can also be combined with one or more additional components, including but not limited to, free urease inhibitor and/or a nitrogen-based fertilizer composition.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 26, 2018
    Applicant: Koch Agronomic Services, LLC
    Inventors: Douglas Barr, Ethel Garnier, Stanley Freeman
  • Publication number: 20150376077
    Abstract: The present invention provides a controlled release, solid fertilizer composition comprising a water-soluble central substrate and at least three layers of a water insoluble coating formed by reacting a polyisocyanate and a polyol and further comprising a coating of an organic wax. The present invention provides a better release profile in relation to the amount of coating materials applied than known fertilizers. Preparation systems and processes are also provided.
    Type: Application
    Filed: May 19, 2015
    Publication date: December 31, 2015
    Inventors: DOUGLAS BARR, Stanley Freeman, Sabesh Kanagalingam
  • Patent number: 8445499
    Abstract: Bipiperidinyl compounds of the formula: are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: May 21, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Harold B. Wood, Alan D. Adams, Stanley Freeman, Jason W. Szewczyk, Conrad Santini, Yong Huang
  • Patent number: 8399485
    Abstract: Bipiperidyl compounds of the formula: (I) are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
    Type: Grant
    Filed: December 10, 2007
    Date of Patent: March 19, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Harold B. Wood, Alan D. Adams, Stanley Freeman, Jason W. Szewczyk, Conrad Santini, Yong Huang, Ralph T. Mosley
  • Publication number: 20120178681
    Abstract: Bipiperidinyl compounds of the formula I, are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
    Type: Application
    Filed: March 21, 2012
    Publication date: July 12, 2012
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: HAROLD B. WOOD, Alan D. Adams, Stanley Freeman, Jason W. Szewczyk, Conrad Santini, Yong Huang
  • Publication number: 20100075987
    Abstract: Bipiperidyl compounds of the formula: (I) are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
    Type: Application
    Filed: December 10, 2007
    Publication date: March 25, 2010
    Inventors: Harold B. Wood, Alan D. Adams, Stanley Freeman, Jason W. Szewczyk, Conrad Santini, Yong Huang, Ralph T. Mosley
  • Publication number: 20100029688
    Abstract: Bipiperidinyl compounds of the formula I, are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
    Type: Application
    Filed: December 14, 2007
    Publication date: February 4, 2010
    Inventors: Harold B. Wood, Alan D. Adams, Stanley Freeman, Jason W. Szewezyk, Conrad Santini, Yong Huang